356 results on '"Casson, Alan G."'
Search Results
2. Supplementary Data from MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
3. Supplementary Data from Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma
4. Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus
5. Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization
6. Posterior Mediastinal or Retrosternal Reconstruction Following Esophagectomy for Cancer
7. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines
8. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium
9. Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
10. Obesity and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: A Mendelian Randomization Study
11. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma
12. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma
13. Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma
14. Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett’s Esophagus, and Gastroesophageal Reflux
15. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
16. BIOLOGY AND EPIDEMIOLOGY OF MALIGNANT ESOPHAGEAL CARCINOMA
17. Contributors
18. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium
19. Loss of Imprinting and Abnormal Expression of the Insulin-Like Growth Factor 2 Gene in Gastric Cancer†
20. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium
21. Regulation of Fibroblast Growth Factor-2 by an Endogenous Antisense RNA and by Argonaute-2
22. Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma
23. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues
24. Shining light on Barrettʼs esophagus
25. Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma
26. Regulation of CDX2 expression in esophageal adenocarcinoma
27. Epidemiology and Molecular Biology of Barrett Esophagus
28. Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells
29. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrettʼs esophagus and esophageal adenocarcinoma
30. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma
31. Validation of the Functional Assessment of Cancer Therapy Esophageal Cancer Subscale
32. Improving Outcomes After Esophagectomy: The Impact of Operative Volume
33. Recent Advances in the Management of Esophageal Adenocarcinoma
34. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma
35. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma
36. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: Loss of expression correlates with poor prognosis
37. Pathologic Complete Response and Survival Advantage in Esophageal Cancer: Old News
38. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study
39. Role of molecular biology in the follow-up of patients who have Barrett's esophagus
40. Dysphagia lusoria: extrathoracic surgical management
41. MUTATIONS OF p53 IN BARRETT'S ESOPHAGUS AND BARRETT'S CANCER: A PROSPECTIVE STUDY OF NINETY-EIGHT CASES
42. Laparoscopic appendicectomy
43. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression
44. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer
45. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma
46. A Study of Smoking, p53 Tumor Suppressor Gene Alterations and Non-Small Cell Lung Cancer
47. What is the optimal distal resection margin for esophageal carcinoma?
48. Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer
49. Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus
50. Waiting for scheduled surgery: A complex patient experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.